Abstract
Objective: The relations between oral contraceptives (OC), hormone replacement therapy (HRT) for menopause, and other female hormone use and thyroid cancer risk was analyzed using the original data from 13 studies from North America, Asia and Europe.
Methods: Based on 2,132 cases and 3,301 controls, odds ratios (OR) and the corresponding 95% confidence intervals (CI) were obtained by conditional regression models, conditioning on study and age at diagnosis, and adjusting for age, radiation exposure and parity.
Results: Overall, 808 (38%) cases versus 1,290 (39%) controls had ever used OCs, corresponding to an OR of 1.2 (95% CI 1.0 to 1.4). There was no relation with duration of use, age at first use, or use before first birth. The OR was significantly increased for current OC users (OR=1.5, 95% 1.0 to 2.1), but declined with increasing time since stopping (OR=1.1 for >10 years since stopping). The association was stronger for papillary cancers (OR=1.6 for current users) than for other histologic types. No significant heterogeneity was observed across studies or geographic areas. Eight studies had data on HRT, for a total of 1,305 cases and 2,300 controls: 110 (8%) cases and 205 (9%) controls reported ever using HRT (OR=0.8; 95% CI 0.6 to 1.1). The ORs were 1.6 (95% to 0.9 to 2.9) for use of fertility drugs, and 1.5 (95% CI 1.1 to 2.1) for lactation suppression treatment.
Conclusions: The studies considered in these analyses include most of the epidemiological data on the role of exogenous hormone use in the etiology of thyroid cancer, and they provide reassuring evidence on the absence of an association of practical relevance. The moderate excess risk in current OC users, if not due to increased surveillance for thyroid masses among OC users, is similar to that described for breast cancer, and would imply a role of female hormones on thyroid cancer promotion. There was no indication of increased thyroid cancer risk 10 or more years after discontinuing OC use.
Similar content being viewed by others
References
Franceschi F, Boyle P, Maisonneuve P, et al. (1993) The epidemiology of thyroid carcinoma. Crit Rev Oncogen 4: 25-52.
Weeke J, Hansen AP (1975) Serum TSH and serum T3 levels during normal menstrual cycles and during cycles on oral contraceptives. Acta Endocrinol 79: 431-438.
McTiernan AM, Weiss NS, Daling JR (1984) Incidence of thyroid cancer in women in relation to reproductive and hormonal factors. Am J Epidemiol 120: 423-435.
Preston-Martin S, Bernstein L, Pike MC, Maldonado AA, Henderson BE (1987) Thyroid cancer among young women related to prior thyroid disease and pregnancy history. Br J Cancer 55: 191-195.
Preston-Martin S, Jin F, Duda MJ, Mack WJ (1993) A case-control study of thyroid cancer in women under age 55 in Shanghai (People's Republic of China). Cancer Causes Control 4: 431-442.
Ron E, Kleinerman RA, Boice JD Jr, et al. (1987) A population-based case-control study of thyroid cancer. J Natl Cancer Inst 79: 1-12.
Franceschi S, Fassina A, Talamini R, et al. (1990) The influence of reproductive and hormonal factors on thyroid cancer in women. Rev Epidém Santé Publ 38: 27-34.
Kolonel LN, Hankin JH, Wilkens LR, Fukunaga FH, Hinds MW (1990) An epidemiological study of thyroid cancer in Hawaii. Cancer Causes Control 1: 223-234.
Hallquist A, Hardell L, Degerman A, Boquist L (1994) Thyroid cancer: reproductive factors, previous diseases, drug intake, family history and diet. A case-control study. Eur J Cancer Prev 3: 481-488.
Galanti MR, Hansson L, Lund E, et al. (1996) Reproductive history and cigarette smoking as risk factors for thyroid cancer in women: a population-based case-control study. Cancer Epidemiol Biomarkers Prev 5: 425-431.
Negri E, Ron E, Franceschi S, et al. A pooled analysis of case-control studies of thyroid cancer. I. Methods. Cancer Causes Control 10: 131-142.
Wingren G, Hatscheck T, Axelson O (1993) Determinants of papillary cancer of the thyroid. Am J Epidemiol 138: 482-491.
Levi F, Franceschi S, Gulie C, Negri E, La Vecchia C (1993) Female thyroid cancer: The role of reproductive and hormonal factors in Switzerland. Oncology 50: 309-315.
Linos A, Linos DA, Vgotza N, Souvatzoglou A, Koutras DA (1989) Does coffee consumption protect against thyroid diseases? Acta Chir Scand 155: 317-320.
Glattre E, Haldorsen T, Berg JP, Stensvold I, Solvoll K (1993) Norwegian case-control study testing the hypothesis that seafood increases the risk of thyroid cancer. Cancer Causes Control 4: 11-16.
Breslow NE, Day NE (1980) Statistical Methods in Cancer Research, Vol. 1, The Analysis of Case-Control Studies. Lyon, IARC: IARC Sci. Publ. No. 32.
La Vecchia C, Tavani A, Franceschi S, Parazzini F (1996) Oral contraceptives and cancer. A review of the evidence. Drug Safety 14: 260-272.
Collaborative Group on Hormonal Factors in Breast Cancer (1996) Breast cancer and hormonal contraceptives. Lancet 347: 1713-1727.
Day NE (1983) Time as a determinant of risk in cancer epidemiology: the role of multistage models. Cancer Surveys 2: 577-593.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Vecchia, C.L., Ron, E., Franceschi, S. et al. A pooled analysis of case-control studies of thyroid cancer¶ III. Oral contraceptives, menopausal replacement therapy and other female hormones. Cancer Causes Control 10, 157–166 (1999). https://doi.org/10.1023/A:1008832513932
Issue Date:
DOI: https://doi.org/10.1023/A:1008832513932